Page last updated: 2024-11-02

oxidopamine and Neuritis

oxidopamine has been researched along with Neuritis in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Neuritis: A general term indicating inflammation of a peripheral or cranial nerve. Clinical manifestation may include PAIN; PARESTHESIAS; PARESIS; or HYPESTHESIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koprich, JB1
Reske-Nielsen, C1
Mithal, P1
Isacson, O1
Donnerer, J1

Other Studies

2 other studies available for oxidopamine and Neuritis

ArticleYear
Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease.
    Journal of neuroinflammation, 2008, Feb-27, Volume: 5

    Topics: Animals; Antirheumatic Agents; Disease Models, Animal; Disease Susceptibility; Dopamine; Female; Int

2008
Improved neurochemical recovery of 6-hydroxydopamine-lesioned postganglionic sympathetic neurons by nerve growth factor in the adult rat.
    Neuroscience letters, 1996, Dec-27, Volume: 221, Issue:1

    Topics: Age Factors; Animals; Capsaicin; Freund's Adjuvant; Male; Microinjections; Nerve Growth Factors; Ner

1996